Annual EBIT
-$20.05 M
-$4.44 M-28.43%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual earnings before interest & taxes is -$20.05 million, with the most recent change of -$4.44 million (-28.43%) on December 31, 2023.
- During the last 3 years, CYTH annual EBIT has fallen by -$11.09 million (-123.77%).
- CYTH annual EBIT is now -6017.98% below its all-time high of $338.80 thousand, reached on December 31, 2013.
Performance
CYTH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.29 M
-$2.65 M-47.09%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly earnings before interest & taxes is -$8.29 million, with the most recent change of -$2.65 million (-47.09%) on September 30, 2024.
- Over the past year, CYTH quarterly EBIT has dropped by -$2.65 million (-46.91%).
- CYTH quarterly EBIT is now -2347.06% below its all-time high of $368.90 thousand, reached on June 30, 2013.
Performance
CYTH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$24.68 M
-$3.52 M-16.65%
September 30, 2024
Summary
- As of February 8, 2025, CYTH TTM earnings before interest & taxes is -$24.68 million, with the most recent change of -$3.52 million (-16.65%) on September 30, 2024.
- Over the past year, CYTH TTM EBIT has dropped by -$4.63 million (-23.08%).
- CYTH TTM EBIT is now -3681.54% below its all-time high of $689.00 thousand, reached on June 30, 2013.
Performance
CYTH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CYTH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.4% | -46.9% | -23.1% |
| 3 y3 years | -123.8% | -46.9% | -23.1% |
| 5 y5 years | -371.3% | -46.9% | -23.1% |
CYTH EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | at low | -199.1% | at low | -89.5% | at low |
| 5 y | 5-year | -171.3% | at low | -477.3% | at low | -233.9% | at low |
| alltime | all time | -6018.0% | at low | -2347.1% | at low | -3681.5% | at low |
Cyclo Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.29 M(+47.1%) | -$24.68 M(+16.6%) |
| Jun 2024 | - | -$5.64 M(+10.3%) | -$21.15 M(+5.0%) |
| Mar 2024 | - | -$5.11 M(-9.5%) | -$20.15 M(+0.5%) |
| Dec 2023 | -$20.05 M(+28.4%) | -$5.64 M(+18.4%) | -$20.05 M(+3.5%) |
| Sep 2023 | - | -$4.77 M(+2.9%) | -$19.38 M(+2.8%) |
| Jun 2023 | - | -$4.63 M(-7.5%) | -$18.86 M(+6.7%) |
| Mar 2023 | - | -$5.01 M(+0.7%) | -$17.68 M(+13.3%) |
| Dec 2022 | -$15.61 M(+9.4%) | -$4.97 M(+17.0%) | -$15.61 M(+16.4%) |
| Sep 2022 | - | -$4.25 M(+22.9%) | -$13.41 M(+3.0%) |
| Jun 2022 | - | -$3.46 M(+17.8%) | -$13.02 M(-1.1%) |
| Mar 2022 | - | -$2.93 M(+5.9%) | -$13.17 M(-7.7%) |
| Dec 2021 | -$14.27 M(+59.2%) | -$2.77 M(-28.2%) | -$14.27 M(+0.6%) |
| Sep 2021 | - | -$3.86 M(+7.2%) | -$14.18 M(+20.6%) |
| Jun 2021 | - | -$3.60 M(-10.8%) | -$11.76 M(+13.5%) |
| Mar 2021 | - | -$4.04 M(+50.6%) | -$10.36 M(+15.6%) |
| Dec 2020 | -$8.96 M(+21.2%) | -$2.68 M(+86.7%) | -$8.96 M(+2.3%) |
| Sep 2020 | - | -$1.44 M(-34.7%) | -$8.76 M(-2.2%) |
| Jun 2020 | - | -$2.20 M(-16.7%) | -$8.96 M(+10.2%) |
| Mar 2020 | - | -$2.64 M(+6.4%) | -$8.13 M(+9.9%) |
| Dec 2019 | -$7.39 M(+73.7%) | -$2.48 M(+52.5%) | -$7.39 M(+18.0%) |
| Sep 2019 | - | -$1.63 M(+18.8%) | -$6.26 M(+15.5%) |
| Jun 2019 | - | -$1.37 M(-28.2%) | -$5.42 M(+1.4%) |
| Mar 2019 | - | -$1.91 M(+40.7%) | -$5.35 M(+25.7%) |
| Dec 2018 | -$4.25 M(+10.8%) | -$1.36 M(+71.7%) | -$4.25 M(-0.6%) |
| Sep 2018 | - | -$789.80 K(-39.0%) | -$4.28 M(+3.7%) |
| Jun 2018 | - | -$1.29 M(+59.0%) | -$4.13 M(+12.7%) |
| Mar 2018 | - | -$814.40 K(-41.0%) | -$3.66 M(-4.9%) |
| Dec 2017 | -$3.84 M(-8.5%) | -$1.38 M(+116.8%) | -$3.85 M(+16.9%) |
| Sep 2017 | - | -$636.90 K(-23.3%) | -$3.29 M(-22.8%) |
| Jun 2017 | - | -$830.90 K(-17.1%) | -$4.27 M(-5.2%) |
| Mar 2017 | - | -$1.00 M(+21.4%) | -$4.50 M(+7.2%) |
| Dec 2016 | -$4.20 M(+74.8%) | -$825.10 K(-48.7%) | -$4.20 M(-2.4%) |
| Sep 2016 | - | -$1.61 M(+51.1%) | -$4.30 M(+25.3%) |
| Jun 2016 | - | -$1.06 M(+52.4%) | -$3.43 M(+26.2%) |
| Mar 2016 | - | -$698.20 K(-24.7%) | -$2.72 M(+13.2%) |
| Dec 2015 | -$2.40 M(+329.4%) | -$927.60 K(+25.4%) | -$2.40 M(+34.7%) |
| Sep 2015 | - | -$739.80 K(+110.0%) | -$1.78 M(+43.7%) |
| Jun 2015 | - | -$352.30 K(-7.4%) | -$1.24 M(+12.7%) |
| Mar 2015 | - | -$380.40 K(+23.0%) | -$1.10 M(+96.7%) |
| Dec 2014 | -$559.00 K(-265.0%) | -$309.20 K(+56.5%) | -$559.10 K(+57.4%) |
| Sep 2014 | - | -$197.60 K(-7.1%) | -$355.10 K(+36.8%) |
| Jun 2014 | - | -$212.70 K(-232.6%) | -$259.60 K(-180.6%) |
| Mar 2014 | - | $160.40 K(-252.5%) | $322.00 K(-5.0%) |
| Dec 2013 | $338.80 K(+110.4%) | -$105.20 K(+3.0%) | $338.80 K(-45.0%) |
| Sep 2013 | - | -$102.10 K(-127.7%) | $615.60 K(-10.7%) |
| Jun 2013 | - | $368.90 K(+108.2%) | $689.00 K(+164.1%) |
| Mar 2013 | - | $177.20 K(+3.3%) | $260.90 K(+62.0%) |
| Dec 2012 | $161.00 K | $171.60 K(-697.9%) | $161.00 K(-315.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$28.70 K(-51.5%) | -$74.70 K(-18.7%) |
| Jun 2012 | - | -$59.20 K(-176.6%) | -$91.90 K(-1047.4%) |
| Mar 2012 | - | $77.30 K(-220.6%) | $9700.00(-113.5%) |
| Dec 2011 | -$72.00 K(+778.0%) | -$64.10 K(+39.7%) | -$71.90 K(-217.9%) |
| Sep 2011 | - | -$45.90 K(-208.3%) | $61.00 K(-36.3%) |
| Jun 2011 | - | $42.40 K(-1086.0%) | $95.70 K(+21.1%) |
| Mar 2011 | - | -$4300.00(-106.3%) | $79.00 K(-1063.4%) |
| Dec 2010 | -$8200.00(-95.8%) | $68.80 K(-714.3%) | -$8200.00(-96.6%) |
| Sep 2010 | - | -$11.20 K(-143.6%) | -$239.30 K(+22.5%) |
| Jun 2010 | - | $25.70 K(-128.1%) | -$195.40 K(-16.3%) |
| Mar 2010 | - | -$91.50 K(-43.6%) | -$233.40 K(+18.9%) |
| Dec 2009 | -$193.10 K(-8.7%) | -$162.30 K(-596.3%) | -$196.30 K(+48.9%) |
| Sep 2009 | - | $32.70 K(-365.9%) | -$131.80 K(-23.7%) |
| Jun 2009 | - | -$12.30 K(-77.4%) | -$172.80 K(-3.6%) |
| Mar 2009 | - | -$54.40 K(-44.4%) | -$179.30 K(-15.2%) |
| Dec 2008 | -$211.40 K(-209.1%) | -$97.80 K(+1078.3%) | -$211.50 K(+227.4%) |
| Sep 2008 | - | -$8300.00(-55.9%) | -$64.60 K(-928.2%) |
| Jun 2008 | - | -$18.80 K(-78.3%) | $7800.00(-92.8%) |
| Mar 2008 | - | -$86.60 K(-276.4%) | $108.90 K(-43.8%) |
| Dec 2007 | $193.70 K(+191.7%) | $49.10 K(-23.4%) | $193.70 K(-17.1%) |
| Sep 2007 | - | $64.10 K(-22.1%) | $233.60 K(+76.8%) |
| Jun 2007 | - | $82.30 K(-4672.2%) | $132.10 K(+259.9%) |
| Mar 2007 | - | -$1800.00(-102.0%) | $36.70 K(-44.7%) |
| Dec 2006 | $66.40 K(-159.0%) | $89.00 K(-338.0%) | $66.40 K(-187.3%) |
| Sep 2006 | - | -$37.40 K(+185.5%) | -$76.10 K(-32.4%) |
| Jun 2006 | - | -$13.10 K(-147.0%) | -$112.50 K(+40.1%) |
| Mar 2006 | - | $27.90 K(-152.1%) | -$80.30 K(-28.6%) |
| Dec 2005 | -$112.60 K(-59.6%) | -$53.50 K(-27.5%) | -$112.50 K(+468.2%) |
| Sep 2005 | - | -$73.80 K(-486.4%) | -$19.80 K(-132.7%) |
| Jun 2005 | - | $19.10 K(-544.2%) | $60.50 K(+12.2%) |
| Mar 2005 | - | -$4300.00(-111.0%) | $53.90 K(+66.9%) |
| Dec 2004 | -$278.90 K(-547.0%) | $39.20 K(+503.1%) | $32.30 K(+498.1%) |
| Sep 2004 | - | $6500.00(-48.0%) | $5400.00(-82.1%) |
| Jun 2004 | - | $12.50 K(-148.3%) | $30.10 K(-30.2%) |
| Mar 2004 | - | -$25.90 K(-310.6%) | $43.10 K(-30.9%) |
| Dec 2003 | $62.40 K(-68.4%) | $12.30 K(-60.6%) | $62.40 K(+169.0%) |
| Sep 2003 | - | $31.20 K(+22.4%) | $23.20 K(-67.0%) |
| Jun 2003 | - | $25.50 K(-486.4%) | $70.40 K(-24.5%) |
| Mar 2003 | - | -$6600.00(-75.5%) | $93.30 K(-52.7%) |
| Dec 2002 | $197.40 K(-932.9%) | -$26.90 K(-134.3%) | $197.20 K(-2.7%) |
| Sep 2002 | - | $78.40 K(+62.0%) | $202.70 K(+91.6%) |
| Jun 2002 | - | $48.40 K(-50.3%) | $105.80 K(+46.9%) |
| Mar 2002 | - | $97.30 K(-554.7%) | $72.00 K(-405.1%) |
| Dec 2001 | -$23.70 K(-74.4%) | -$21.40 K(+15.7%) | -$23.60 K(-76.4%) |
| Sep 2001 | - | -$18.50 K(-226.7%) | -$99.90 K(+5.3%) |
| Jun 2001 | - | $14.60 K(+758.8%) | -$94.90 K(-13.3%) |
| Mar 2001 | - | $1700.00(-101.7%) | -$109.50 K(-1.5%) |
| Dec 2000 | -$92.40 K | -$97.70 K(+623.7%) | -$111.20 K(+723.7%) |
| Sep 2000 | - | -$13.50 K | -$13.50 K |
FAQ
- What is Cyclo Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual EBIT year-on-year change?
- What is Cyclo Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly EBIT year-on-year change?
- What is Cyclo Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cyclo Therapeutics?
- What is Cyclo Therapeutics TTM EBIT year-on-year change?
What is Cyclo Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CYTH is -$20.05 M
What is the all time high annual EBIT for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual earnings before interest & taxes is $338.80 K
What is Cyclo Therapeutics annual EBIT year-on-year change?
Over the past year, CYTH annual earnings before interest & taxes has changed by -$4.44 M (-28.43%)
What is Cyclo Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CYTH is -$8.29 M
What is the all time high quarterly EBIT for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly earnings before interest & taxes is $368.90 K
What is Cyclo Therapeutics quarterly EBIT year-on-year change?
Over the past year, CYTH quarterly earnings before interest & taxes has changed by -$2.65 M (-46.91%)
What is Cyclo Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CYTH is -$24.68 M
What is the all time high TTM EBIT for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM earnings before interest & taxes is $689.00 K
What is Cyclo Therapeutics TTM EBIT year-on-year change?
Over the past year, CYTH TTM earnings before interest & taxes has changed by -$4.63 M (-23.08%)